Planned
There are currently no planned studies in our center.
Ongoing
There are currently no ongoing studies in our center.
Closed
CABOGIST EORTC 1317
Phase II Study of Cabozantinib in Patients With Gastrointestinal Stromal Tumor (GIST) Who Progressed During Neoadjuvant, Adjuvant or Palliative Therapy With Imatinib and Sunitinib
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02216578
INTRIGUE DCC-2618-03-002
A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT03673501
INVICTUS DCC2618-03-001
Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT03353753
NAVIGATOR BLU-285-1101
A Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02508532
VOYAGER BLU-285-1303
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT03465722